Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Differentiation of hypercalcaemia due to malignancy from primary hyperparathyroidism: The value of parathyroid hormone and plasma bicarbonate measurements

  • 21 Accesses

  • 4 Citations

Summary

Parathyroid hormone levels in primary hyperparathyroid patients and patients with malignant disease and hypercalcaemia are reported. The value of PTH measurement in conjunction with serum calcium and bicarbonate values in differential diagnosis is discussed. Theories for the production of hypercalcaemia in malignant disease are reviewed.

This is a preview of subscription content, log in to check access.

References

  1. Almquist, S., Hjern, B. and Wasthed, B. 1975. The diagnostic value of radioimmunoassay for parathyroid in human serum. Acta Endocrinologica. 78, 493.

  2. Benson, R. C., Riggs, B. L., Pickard, B. M., Arnaud, C. D. 1974. Radioimmunoassay of parathyroid hormone in hypercalcaemic patients with malignant disease. Am. J. Med. 56, 821.

  3. Berson, S. A. and Yalow, R. S. 1968. Immunochemical heterogeneity of parathyroid hormone in plasma. J. Clin. Endocrinol. & Metab. 28, 1037.

  4. Berson, S. A. and Yalow, R. S. 1966. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uraemia and bronchogenic carcinoma. Science. 154, 907.

  5. Canterbury J. and Reiss, E. 1972. Multiple immunoreactive forms of parathyroid hormone in human serum. Proc. Soc. Exp. Biol. Med. 140, 1393.

  6. DiBella, F. P., Kehrwald, J. M., Laakso, K. and Zitner, L. 1978. Parathyrin radioimmunoassay: diagnostic utility of antisera produced against C terminal fragments of the hormone from the human. Clin. Chem. 24, 451.

  7. Easty, G. C., Dowsett, M., Powles, T. J., Easty, D. M., Gazet, G. C., Neville, A. M. 1977. In vitro osteolysis by human breast tumours. Proc. R. Soc. Med. 20, 191.

  8. Farr, H. W., Fahey, T. J., Nash, A. G., Farr, C. M. 1973. Primary hyperparathyroidism and canctr. Amer. J. Surg. 126, 539.

  9. Freitag, J., Martin, K. J., Hruska, K. A., Anderson, C., Conrades, M., Ladenson, J., Klahr, S. Slatopolsky, E. 1978. Impaired parathyroid normone metabolism in patients with chronic renal failure. New Eng. 3. Med. 298, 29.

  10. Freaney, R. and Muldowney, F. P. 1977. Clinical value of serum parathyroid hormone measurements. J. Ir. Med. Assoc. 70, 317.

  11. Gordon, G. S., Cantino, T. J., Erhardt, Z., Hansen, J., Lubich, W. 1966. Osteolytic sterol in human breast cancer. Science. 151, 1226.

  12. Haddad, J. G., Gouraz, S. J., Avioli, L. V. 1970. Circulating phytosterols in normal females, lactating mothers and breast cancer patients. J. Clin. Endocr. 30, 174.

  13. Heath, D. A. and Aurbach, C. D. 1975. Ectopic production of parathyroid hormone: a prototype of a non-endocrine hormone synthesis. Endocrinology and Diabetes. Eds. L. J. Kryston and R. A. Shaw. New York. Grune & Stratton. p. 215.

  14. Heath, D. A., Shimkin, P. M., Wolfe, D. R. 1974. Pre-operative diagnosis of primary hyperparathyroidism by selective venous catheterisation of neck veins in patients with known malignant disease. J. Clin. Endocr. 38, 618.

  15. Kaplan, L., Katz, A. D., Ben-Issac, C., Massry, S. G. 1971. Malignant neoplasms and parathyroid adenoma. Cancer. 28, 401.

  16. Karim, S. M. M. 1976. Prostaglandins and tumours. Advances in Prostaglandin Research. Lancaster. M.T.P. Press. p. 303.

  17. Martin, K. J., O'Connor, P., Muldowney, F. P., McMullin, J. P., McDowell, D. and Towers, R. P. 1978. Primary Hyperparathyroidism: A refview of 35 cases. Irish J. Med. Sci. 147, 62.

  18. Muldowney, F. P., Freaney, R. and Brennan, P. 1965. A case of osteomalacia and renal tubular acidosis associated with occult idiopathic steatorrhoea: the effect of vitamin D on renal tubular hydrion transport. Irish J. Med. Sci. 480, 436.

  19. Muldowney, F. P., Freaney, R. and McGeeney, D. M. 1968. Renal tubular acidosis and amino aciduria in osteomalacia of dietary or intestinal origin. Quart. J. Med. 37, 517.

  20. Muldowney, F. P., Donohoe, J. F., Freney, R., Kampiff, C. and Swan, M. 1970. Parathormone in induced renal bicarbonat wastage in intestinal malbsorption nd in chronic renal failure. Irish J. Med. Sci. 3, 221.

  21. Muldowney, F. P., Carroll, D. V., Donohoe, J. F. and Freaney, R. 1971. Correction of renal bicarbonate wastage by parathyroidectomy. Quart. J. Med. 40, 487.

  22. Muldowney, F. P., Williams, P. T. and Freaney, R., and Carroll, D. V., Donohoe, J. F. and Powell, D. 1972. Parathyroid acidosis. Proceedings of the Association of Physicians of Great Britain and Ireland. Quart. J. Med. 41, 524.

  23. Muldowney, F. p. 1979. Renal Disease. Eds. Sir Douglas Black and N. F. Jones. London. Blackwell Scientific Publications, p. 588.

  24. Mundy, G. R., Raisz, L. G., Cooper, R. A., Schechter, G. P., Salmon, S. E. 1974. Evidence of the secretion of an osteoclast stimulating factor in myeloma. New Engl. J. Med. 291. 1041.

  25. Mundy, G. R., Lukan, R. A., Raisz, L. G.et al. 1974. Bone resorbing activity in supernatants from lymphoid cell lines. New Engl. J. Med. 290, 867.

  26. Orr, W., Varani, J., Gondek, M. D., Ward, P. A., Mundy, G. R. 1979. Chemotactic responses of tumour cells to products of resorbing bone. Science, 203, 176.

  27. Powles, T. J., Clark, S. A., Easty, D. M., Easty, G. C., Neville, A. M. 1976. the inhibition by Aspirin and Indomethacin of osteolytic deposits and hypercalcaemia in rats with Walker tumour and its possible application to human breast cancer. Brit. J. Cancer. 28, 316.

  28. Powles, T. J., Dowsett, M., Easty, G. C., Easty, D. M., Neville, A. M. 1976. Breast cancer osteolysis, bone metastases and anti-osteolytic effect of aspirin. Lancet i 608.

  29. Raisz, L. G., Yandick, C., Bockman, R. S., Bower, B. F. 1979. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcaemia due to primary hyperparathyroidism and malignancy. Ann. Int. Med. 91, 739.

  30. Riggs, B. L., Arnaud, C. D., Reynolds, J. C., Smith, L. H. 1971. Immunological differentiation of primary hyperparathyroidism from hyperparathyroidism due to non-hyperparathyroid cancer. J. clin. Invest. 50, 2079.

  31. Segre, G. U., Habener, J. F., Powell, D., Tregear, G. W., Potts, J. T. (Jr.). 1972. Parathyroid hormone in human plasma: Immunochemical characterisation and biological implications. J. Clin. Invest. 51, 3163.

  32. Seyberth, H. W., Segre, G. U., Morgan, S. L., Sweetman, B. J., Potts, J. T., Oakes, J. A. 1975. Prostaglandins as mediators of hypercalcaemia associated with certain types of cancer. New Engl. J. Med. 293, 1278.

  33. Seyberth, H. W., Hubbard, W. C., Oelz, O., Sweetman, B. J., Watson, J. T. and Oates, J.A. 1977. Prostaglandin mediated hypercalcaemia in the VX2 carcinoma bearing rabbit. Prostaglandin 14, 319.

  34. Silverhan, R. and Yalow, R. S. 1973. Heterogeneity of parathyroid hormone. Clinical and physiological implications. J. Clin. Invest. 52, 1958.

  35. Tashjian, A. H., Voelkel, E. F., Goldhaber, P., Levine, A. 1974. Prostaglandins, calcium metabolism and cancer. Fed. Proc. 33, 81.

  36. Voelkel, E. F., Tasjian, A. H., Franklin, R., Wasserman, E. and Levine, L. 1975. Hypercalcaemia and tumour prostaglandin. The VX2 carcinoma model white rabbit. Metabolism 24, 973.

  37. Wills, M. R. 1971. Value of plasma chloride concentration and acid base status in the differential diagnosis of hyperparathyroidism from outer Causes of hypercalcaemia. J. Clin. Path. 29, 219.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Freaney, R., Ryan, E. & Muldowney, F.P. Differentiation of hypercalcaemia due to malignancy from primary hyperparathyroidism: The value of parathyroid hormone and plasma bicarbonate measurements. I.J.M.S. 150, 6 (1981). https://doi.org/10.1007/BF02938185

Download citation

Keywords

  • Parathyroid Hormone
  • Serum Calcium
  • Malignant Disease
  • Primary Hyperparathyroidism
  • Parathyroid Adenoma